Wegovy is rewriting the rules of cardiovascular care with a groundbreaking new approval
Wegovy, the injectable medication best known for its role in weight management, has just been cleared for a purpose that extends well beyond the scale. Britain’s national health technology authority has recommended Wegovy for use in reducing the risk of major cardiovascular events, including heart attacks, strokes, and cardiovascular death, in adults who are living […]
Semaglutide may lead to rare eye condition, study shows
A recent study published in JAMA Ophthalmology has highlighted a potential link between semaglutide, a medication commonly used for diabetes and weight loss, and a rare eye condition known as nonarteritic anterior ischemic optic neuropathy (NAION), which can lead to blindness. Key findings of the study A significant association was found between the use of […]
Nutritional guidelines for GLP-1 medication users
Recent studies have highlighted the importance of tailored nutritional guidelines for individuals using GLP-1 medications for weight loss. These drugs, effective in reducing appetite and aiding significant weight loss, include FDA-approved Wegovy and others like Ozempic and Saxenda used off-label. However, the reduced food intake associated with these medications raises concerns about potential nutritional deficiencies. […]
Zepbound: A promising anti-obesity medication for individuals with chronic conditions
New research highlights the effectiveness of the anti-obesity medication Zepbound (tirzepatide) in promoting significant weight loss, even for individuals with multiple obesity-related chronic conditions. This groundbreaking study challenges the previous belief that chronic health issues hinder weight loss efforts. Understanding obesity and its associated chronic conditions Obesity is a major health concern that can lead […]